Prof. Dr. Maria Elena Torres Padilla
Director of Biomedicine
Director, Institute of Epigenetics and Stem Cells Helmholtz Munich
Professor of Stem cell biology, LMU Munich
Prof. Dr. Vasilis Ntziachristos
Director of Bioengineering
Director, Institute of Biological and Medical Imaging Helmholtz Munich
Professor of Medicine and Electrical Engineering; Chair of Biological Imaging; Technical University of Munich
Prof. Dr. Fabian Theis
Director of Biomedical AI
Director of the Computational Health Center
Director of the Institute for Computational Biology
Professor of Mathematical Modelling of Biological Systems; Technical University of Munich
Dr. Thomas Schwarz-Romond
Director of Operations
Member of the extended Executive Board of the Helmholtz Munich
Thomas is spearheading the overall deployment, international recruitment and strategic positioning of the Helmholtz Pioneer Campus.
The Steering Committee advises the HPC Board of Directors with regard to scientific strategy, and fosters national and international visibility to attract outstanding scientific talents. The Steering Committee members contribute to the regular quality control/peer-selection of HPC principal investigator applications. They are instrumental in accelerating HPC's integration within the Munich-based, as well as international scientific community and amplify HPC's global ambition as an innovator-hub at the interface of bioengineering, biomedicine and bioinformatics.
Members of the Steering Committee
- Prof. Magdalena Götz, Institute of Stem Cell Research
- Prof. Stephan Herzig, Institute for Diabetes and Cancer
- Prof. Martin Hrabe de Angelis, Institute of Experimental Genetics
- Prof. Heiko Lickert, Institute of Diabetes and Regeneration Research
- Prof. Michael Sattler, Institute of Structural Biology
- Prof. Fabian Theis, Institute for Computational Biology
- Prof. Juliane Winkelmann, Institute for Neurogenomics
- Prof. Wolfgang Wurst, Institute of Developmental Genetics
- Prof. Eleftheria Zeggini, Institute for Translational Genomics
The Scientific Advisory Board (SAB) provides an objective and external perspective to HPC and ensures the quality and international standards of HPC’s scientific and institutional operations. Specifically, the SAB advises the HPC Board of Directors on emerging global scientific trends and research priorities. The SAB also contributes to HPC's international visibility, enables scientific collaborations and partnerships, and serves a crucial role in the peer-evaluation of HPC scientists at the time of contract renewals.
Members of the Scientific Advisory Board
- Prof. Steven Chu; Stanford University, Stanford, USA
- Prof. Amanda Fisher; MRC London Institute of Medical Sciences, London, UK
- Prof. Matthias Mann; Max Planck Institute of Biochemistry, Munich, Germany
- Prof. Stephen Quake; Stanford University and Chan Zuckerberg Biohub, USA
- Dr. Scott Sternson; HHMI - Janelia Research Campus, Ashburn, USA